Luminex Corporation (NASDAQ:LMNX), a developer of biological testing technologies, reported third-quarter fiscal 2011 earnings of 5 cents a share, narrowly missing the Zacks Consensus Estimate of 6 cents.
The Texas-based company, however, turned in a profit in the quarter on the back of solid sales and lower tax. Luminex posted a profit of $1.9 million in the third quarter versus a loss of $0.7 million (or 2 cents a share) a year ago.
Revenue and Margins
Revenues cruised 34% year over year to $45.6 … [visit site to read more] or compare Credit Card Rewards and Best Credit Cards